GPR161 anticorps
-
- Antigène Voir toutes GPR161 Anticorps
- GPR161 (G Protein-Coupled Receptor 161 (GPR161))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp GPR161 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Antigen affinity purification
- Immunogène
- Synthetic peptide of human GPR161
- Isotype
- IgG
- Top Product
- Discover our top product GPR161 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:30-1:150, ELISA 1:5000-1:10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.2 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- GPR161 (G Protein-Coupled Receptor 161 (GPR161))
- Autre désignation
- GPR161 (GPR161 Produits)
- Synonymes
- anticorps RE2, anticorps Gm208, anticorps Gm208Gpr, anticorps vl, anticorps RGD1563245, anticorps si:bz20i5.4, anticorps si:rp71-20i5.4, anticorps G protein-coupled receptor 161, anticorps GPR161, anticorps Gpr161, anticorps gpr161
- Sujet
- The protein encoded by this gene is an orphan G protein-coupled receptor whose ligand is unknown. This gene is overexpressed in triple-negative breast cancer, and disruption of this gene slows the proliferation of basal breast cancer cells. Therefore, this gene is a potential drug target for triple-negative breast cancer.
- Poids moléculaire
-
Observed_MW: Refer to figures
Calculated_MW: 59 kDa
- UniProt
- Q8N6U8
- Pathways
- cAMP Metabolic Process
-